ARMA-Design: Optimal Treatment Allocation Strategies for A/B Testing in Partially Observable Time Series Experiments
Ke Sun, Linglong Kong, Hongtu Zhu, Chengchun Shi

TL;DR
This paper develops optimal treatment allocation strategies for A/B testing in partially observable time series experiments, using autoregressive models and reinforcement learning, validated on simulations and real ride-sharing data.
Contribution
It introduces a new model for partial observability in online experiments and proposes algorithms for optimal design using constrained optimization and reinforcement learning.
Findings
Proposed algorithms outperform traditional methods in simulations.
Validated designs improve treatment effect estimation accuracy.
Demonstrated effectiveness on real ride-sharing datasets.
Abstract
Online experiments %in which experimental units receive a sequence of treatments over time are frequently employed in many technological companies to evaluate the performance of a newly developed policy, product, or treatment relative to a baseline control. In many applications, the experimental units receive a sequence of treatments over time. To handle these time-dependent settings, existing A/B testing solutions typically assume a fully observable experimental environment that satisfies the Markov condition. However, this assumption often does not hold in practice. This paper studies the optimal design for A/B testing in partially observable online experiments. We introduce a controlled (vector) autoregressive moving average model to capture partial observability. We introduce a small signal asymptotic framework to simplify the calculation of asymptotic mean squared errors of…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPesticide Residue Analysis and Safety · Statistical Methods in Clinical Trials
